MRI Parenchymal Enhancement: A New Marker of Breast Cancer Risk

Memorial Sloan Kettering Cancer Center (MSK)

Status: Completed

Conditions: Cancer Free Women

Treatments: Behavioral: questionnaire

Study type: Observational

Funder types: Other; NIH

Identifiers

NCT01649661

12-125

Details and patient eligibility

About

The purpose of this study is to learn about how a woman's health history influences what a normal breast looks like on an MRI. The investigators also want to learn about how the amount of different natural hormones a woman has affects how the breast looks on an MRI. The investigator's hope is that this will help to find women at a high-risk of breast cancer.

Enrollment: 437 patients

Sex: Female

Ages: 21+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• age 21 years or older
• be a cancer-free pre- or postmenopausal woman
• have no prior personal history of any cancer (including DCIS, excluding nonmelanoma skin-cancer)
• able to speak and read English because the questionnaire is only available in English
• able to provide informed consent

Exclusion criteria

• are pregnant at the time of MRI
• have a prior personal history of any cancer (including DCIS, excluding nonmelanoma skin cancer)

Trial design

437 participants in 2 patient groups

premenopausal women

Description:

Only women already scheduled for a breast MRI will be included in the study, no additional MRIs will be scheduled for study purposes.

Treatment:

Behavioral: questionnaire

postmenopausal women

Description:

Only women already scheduled for a breast MRI will be included in the study, no additional MRIs will be scheduled for study purposes.

Treatment:

Behavioral: questionnaire